“It’s not just about surviving, it’s about so much more” - Alfred’s story 11 Jan 2023 When Alfred Samuels was diagnosed with advanced prostate cancer in 2012, it felt as if his world had fallen apart overnight. Doctors said surgery wasn’t an option for him because the cancer had spread beyond his prostate, and he started to lose hope. But then he joined a clinical trial and began treatment with abiraterone, a drug discovered and developed by our scientists, which is now extending the lives of thousands of men worldwide. Eleven years later, Alfred explains how he wouldn’t be here today without our research. Find out more Show/Hide
“Abiraterone gave my husband time to live life to the full” - Sue's story 26 Mar 2021 Sue’s husband, Philip, was entered onto a clinical trial for abiraterone when his prostate cancer developed resistance to the treatment he was on. She tells us what a difference it made to their lives. Find out more Show/Hide
Men’s Health Week: How our researchers are transforming prostate cancer treatment 15 Jun 2020 Professor Nick James, Chief Investigator of the STAMPEDE trial, joined the ICR in December 2019 and is one of our newest Team Leaders. Diana Cano Bordajandi met him to find out more about his current research and future plans, which will help us answer key questions on how to treat men with prostate cancer. Find out more Show/Hide
The NHS at 70 – how three ICR discoveries have helped improve the lives of people with cancer 02 Jul 2018
ASCO 2017: Using targeted cancer drugs earlier in treatment – abiraterone benefits prostate cancer patients at diagnosis 06 Jun 2017